Thoughts on inducibility

With great interest we read the manuscript of Mahida et al. who analysed the outcome of different treatment strategies for ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)1. They compared the time to VT recurrence after prescribing antiarrhythmic drugs with the time to VT recurrence after ablation. When endocardial and combined endo-epicardial ablation were compared, an advantage (p=0.05) for the combined approach was observed1. No impact on mortality was found, irrespective of whether ablation or drug therapy was applied1.

Source: Heart Rhythm - January 3, 2019 Category: Cardiology Authors: Andreas M üssigbrodt, Arash Arya, Livio Bertagnolli, Borislav Dinov, Gerhard Hindricks Source Type: research